Tradestie Institutional Equity Comparison Engine

RAPT vs ARVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RAPT Overall Edge

RAPT Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to RAPT Therapeutics, Inc. Common Stock (RAPT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ARVN counters with relative strength in Valuation. Fundamentally, RAPT trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus ARVN at 17.9x Forward P/E and -10.1% operating margin (-98.8% YoY). In options structure, RAPT sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against ARVN sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARVN
RAPT N/M vs ARVN 17.9x Fwd P/E
Growth & Margin Winner RAPT
Op Margin 0.0% vs -10.1% ยท YoY -100.0% vs -98.8%
Momentum & Technical Winner RAPT
1Y +480.2% vs -33.4% ยท 52W Pos 100% vs 5%
Options & Structure Winner RAPT
UNCLASSIFIED (<1st %ile IV) vs BREAKDOWN (25th %ile IV)
RAPT NASDAQ
RAPT Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$58.02
+0.07% 1D
Market Cap $1.7B
1M Return +0.68%
1Y Return +480.2%
Forward P/E N/M
Unified AI Score
52.4 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 61.0 Mom 40.0
ARVN NASDAQ
Arvinas, Inc
Pharmaceutical Preparations
$6.74
-1.17% 1D
Market Cap $449.9M
1M Return -3.3%
1Y Return -33.4%
Forward P/E 17.9x
Unified AI Score
52.9 / 100 HOLD
Tech 54.0 Fund 59.0 Flow 71.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RAPT +480.2% ARVN -33.4% Spread: +75.27 pp (RAPT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RAPT TTM Op. Margin: 0.0% ARVN TTM Op. Margin: -10.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RAPT vs ARVN. Trailing 12-month operating profitability (RAPT 0.0% vs ARVN -10.1%) and valuation multiples (RAPT N/M vs ARVN 17.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RAPT (5) vs ARVN (5)
Institutional Metric RAPT ARVN Criterion Row Winner
Market Capitalization Scale $1.7B $449.9M Larger Scale RAPT
Trailing P/E Ratio Valuation N/M 17.9x Lower Multiple ARVN
Forward P/E Ratio Valuation N/M 17.9x Lower Multiple ARVN
Revenue Growth (YoY) Growth -100.0% -98.8% Higher Growth ARVN
Operating Margin (TTM) Profitability 0.0% -10.1% Higher Margin RAPT
Net Profit Margin Profitability 0.0% -3.5% Higher Margin RAPT
Return on Equity (ROE) Capital Efficiency -85.4% -1.8% Higher ROE ARVN
52-Week Range Position Momentum 100% ($1โ€“$58) 5% ($6โ€“$15) Stronger Trend RAPT
Beta / 30D Volatility Risk Regime -0.02ฮฒ ยท 2% Vol 1.40ฮฒ ยท 66% Vol Lower Realized Risk RAPT
Unified Institutional Score Composite Signal 52.4 / 100 (HOLD) 52.9 / 100 (HOLD) Higher Composite ARVN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RAPT vs ARVN Buy Guide
RAPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live RAPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARVN BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ARVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RAPT nor ARVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.